The marker of adverse prognosis 1.5-anhydroglucitol in patients with coronary heart disease in the long-term period after planned myocardial revascularization
Ignatova, Yu S, Karetnikova, V N, Horlampenko, A A, Gruzdeva, O V, Dyleva, Yu A, Barbarash, O L
Published in Terapevtic̆eskii arhiv (16.05.2019)
Published in Terapevtic̆eskii arhiv (16.05.2019)
Get full text
Journal Article
Visceral adiposity index in patients with coronary artery disease, obesity and type 2 diabetes
Khorlampenko, A. A., Karetnikova, V. N., Kochergina, A. M., Ignatova, Yu. S., Belik, E. V., Gruzdeva, O. V., Brel, N. K., Kokov, A. N., Barbarash, O. L.
Published in Kardiovaskuli͡a︡rnai͡a︡ terapii͡a︡ i profilaktika (03.07.2020)
Published in Kardiovaskuli͡a︡rnai͡a︡ terapii͡a︡ i profilaktika (03.07.2020)
Get full text
Journal Article